Nutritional Growth Solutions Raises AU$2 Million to Accelerate Growth
Nutritional Growth Solutions Limited (ASX: NGS) has received firm commitments from sophisticated and professional investors to raise AU$2 million via a share placement at AU$0.02 per share, issuing up to 100 million new fully paid ordinary shares, subject to shareholder approval at the upcoming December 2025 EGM. Proceeds will be used to expand sales and marketing, build inventory to support portfolio and distribution growth, fund general corporate activities, and pursue both organic and inorganic growth opportunities.
Taurus Capital Group Pty Ltd acted as lead manager and will receive a 6% placement fee plus 25 million options exercisable at AU$0.025 for three years, subject to approval. CEO Stephen Turner said the raise strengthens NGS’s position to scale its clinically tested nutrition products and drive further market expansion across the 3–12-year-old pediatric segment.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
Nutritional Growth Solutions Raises AU$2 Million to Accelerate Growth
Nutritional Growth Solutions Limited (ASX: NGS) has received firm commitments from sophisticated and professional investors to raise AU$2 million via a share placement at AU$0.02 per share, issuing up to 100 million new fully paid ordinary shares, subject to shareholder approval at the upcoming December 2025 EGM. Proceeds will be used to expand sales and marketing, build inventory to support portfolio and distribution growth, fund general corporate activities, and pursue both organic and inorganic growth opportunities.
Taurus Capital Group Pty Ltd acted as lead manager and will receive a 6% placement fee plus 25 million options exercisable at AU$0.025 for three years, subject to approval. CEO Stephen Turner said the raise strengthens NGS’s position to scale its clinically tested nutrition products and drive further market expansion across the 3–12-year-old pediatric segment.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au